financetom
Business
financetom
/
Business
/
BMO on Corus Entertainment's "Very Uncertain" Outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BMO on Corus Entertainment's "Very Uncertain" Outlook
Jul 16, 2024 10:32 AM

01:07 PM EDT, 07/16/2024 (MT Newswires) -- Corus Entertainment's third quarter results missed and the near-term outlook remains challenging given a weak TV advertising market and the eventual loss of WBD content in Q2/F25, notes BMO.

Third quarter revenue decreased -16% (-4% below expectations) while EBITDA was -30% (-19% below). TV advertising revenue declined -15%. Adj. EPS was -$0.10 vs. $0.07 Street. Consolidated margins weakened 400bps to ~20% due to revenue declines outpacing cost reduction efforts,

The newly appointed co-CEOs' priorities include cost cutting, optimizing core assets, and attaining covenant relief. However, analyst Tim Casey says "the near-term outlook is very uncertain."

Corus is rated Market Perform.

Price: 0.12, Change: -0.04, Percent Change: -22.58

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Update: Rocket Mortgage Countersues US Housing Authority Over Accusations of Discriminatory Appraisals
Update: Rocket Mortgage Countersues US Housing Authority Over Accusations of Discriminatory Appraisals
Dec 6, 2024
03:37 AM EST, 12/06/2024 (MT Newswires) -- (Update with a response from the US Department of Housing and Urban Development in the last paragraph.) Rocket Companies ( RKT ) subsidiary Rocket Mortgage said Thursday it has countersued the US Department of Housing and Urban Development to remove a case against it over allegedly discriminatory housing appraisals. The company also filed...
Dec 6, 2024
...
Teva Pharmaceutical to Divest Japanese Venture to JKI
Teva Pharmaceutical to Divest Japanese Venture to JKI
Dec 6, 2024
03:31 AM EST, 12/06/2024 (MT Newswires) -- Teva Pharmaceutical Industries ( TEVA ) said late Thursday it has agreed to divest all shares of Teva Takeda Pharma and its Teva Takeda Yakuhin subsidiary to JKI, which was established by the fund managed and operated by J-Will Partners. Financial terms were not disclosed. All the employees of the transferred business venture...
Confluent Insider Sold Shares Worth $1,989,297, According to a Recent SEC Filing
Confluent Insider Sold Shares Worth $1,989,297, According to a Recent SEC Filing
Dec 6, 2024
03:36 AM EST, 12/06/2024 (MT Newswires) -- Erica Schultz, President, Field Operations, on December 03, 2024, sold 63,729 shares in Confluent (CFLT) for $1,989,297. Following the Form 4 filing with the SEC, Schultz has control over a total of 1,064,516 shares of the company, with 678,016 shares held directly and 386,500 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1699838/000141588924028429/xslF345X05/form4-12052024_071201.xml ...
Copyright 2023-2025 - www.financetom.com All Rights Reserved